This federal contract award, with ID SPE2DB22D1106 and SPE2DB25FDPK5, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,127.55, is for the delivery of ORGOVYX 120 MG TABLET, a pharmaceutical product.
The award is a delivery order contract with a firm fixed price pricing type, and the ultimate completion date is December 30, 2024. This contract is not designated with any set-aside requirements, indicating open competition.
AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, covering similar medical products and prescription drugs.
Generated 3/7/25, 9:52 AM